Financhill
Buy
51

PHAR Quote, Financials, Valuation and Earnings

Last price:
$17.95
Seasonality move :
-2.42%
Day range:
$17.21 - $18.10
52-week range:
$7.50 - $18.12
Dividend yield:
0%
P/E ratio:
1,265.04x
P/S ratio:
3.41x
P/B ratio:
4.68x
Volume:
15.7K
Avg. volume:
22.3K
1-year change:
71.47%
Market cap:
$1.2B
Revenue:
$296.7M
EPS (TTM):
$0.01

Earnings Data

Next earnings date for PHAR
Mar 12
2026
Most recent earnings per share
$0.11
Beat by $0.10
(Nov 6/2025)
Consensus Estimate
$0.00
(Nov 6/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

PHAR Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/12/2026 Q4 $101.9M -- -- $0.02 --
11/06/2025 Q3 $91.2M $96.9M $0.11 $0.00 $0.10
07/31/2025 Q2 $82.5M $94.4M $0.07 -$0.01 $0.08
05/08/2025 Q1 $64.1M $79.2M -$0.22 -$0.03 -$0.19
03/13/2025 Q4 $80.6M $92M $0.05 $0.01 $0.05
10/24/2024 Q3 $76M $75.1M -$0.02 -$0.00 -$0.01
08/01/2024 Q2 $72M $74M -$0.02 -$0.00 -$0.02
05/08/2024 Q1 $69.9M $55.5M -$0.19 $0.01 -$0.19
03/14/2024 Q4 -- $81.9M -$0.04 $0.00 -$0.05
10/26/2023 Q3 -- $66.3M $0.05 -- --
08/03/2023 Q2 -- $54.8M $0.02 -- --
05/11/2023 Q1 -- $42.7M -$0.19 -- --
03/16/2023 Q4 -- $55.1M -$0.22 -- --
10/27/2022 Q3 -- $54M $0.13 -- --
08/04/2022 Q2 -- $49.8M $0.21 -- --
05/12/2022 Q1 -- $46.5M $0.05 -- --
03/17/2022 Q4 -- $52.6M $0.03 -- --
10/28/2021 Q3 -- $52.7M -$0.01 -- --
08/05/2021 Q2 -- $49.6M $0.09 -- --
05/13/2021 Q1 -- $43.4M $0.13 -- --
03/04/2021 Q4 -- $60.8M $0.14 -- --
09/30/2020 Q3 -- $53.9M $0.12 -- --
06/30/2020 Q2 -- $43.3M $0.15 -- --
03/31/2020 Q1 -- $54.3M $0.12 -- --
12/31/2019 Q4 -- $50.6M $0.20 -- --
09/30/2019 Q3 -- $50.5M $0.18 -- --
06/30/2019 Q2 -- $48M $0.12 -- --
03/31/2019 Q1 -- $40M $0.11 -- --
12/31/2018 Q4 -- $42M $0.19 -- --
09/30/2018 Q3 -- $45.2M $0.10 -- --
06/30/2018 Q2 -- $35.7M $0.06 -- --
03/31/2018 Q1 -- $36.2M $0.10 -- --
12/31/2017 Q4 -- $38.7M -$0.86 -- --
09/30/2017 Q3 -- $30.6M -$0.18 -- --
06/30/2017 Q2 -- $16.7M -$0.56 -- --
03/31/2017 Q1 -- $16.5M -$0.13 -- --
12/31/2016 Q4 -- $7.7M -$0.18 -- --
09/30/2016 Q3 -- $3.8M -$0.10 -- --
06/30/2016 Q2 -- $3.5M -$0.09 -- --
03/31/2016 Q1 -- $2.4M -$0.09 -- --
12/31/2015 Q4 -- $2.6M -$0.11 -- --

Pharming Group NV Earnings Questions

  • How Much did Pharming Group NV Generate in Revenue Last Quarter?

    Pharming Group NV reported $96.9M worth of top line sales in its most recent quarter.

  • Did Pharming Group NV Beat Earnings Last Quarter?

    Pharming Group NV announced earnings per share of $0.11 which represents a beat of analyst forecast a $0.00 per share.

  • Is Pharming Group NV Profitable?

    Pharming Group NV reported $89.8M that represents $1.31 per share over the last quarter.

  • What is the Analyst Consensus for Pharming Group NV EPS Next Year?

    Pharming Group NV's earnings are forecast to decrease from -$0.18 per share to -$0.01 per share next year representing a decrease of -96.59%.

  • When is Pharming Group NV's Earnings Date?

    Pharming Group NV's next earnings date is March 12, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
57
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
80
TVTX alert for Dec 25

Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.

Buy
68
KOD alert for Dec 25

Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.

Buy
64
ZCSH alert for Dec 25

Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock